Human Immune System Mouse Core
人体免疫系统鼠标核心
基本信息
- 批准号:10238750
- 负责人:
- 金额:$ 16.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-07-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAddressAdultAnimal ModelAnimalsAntibodiesAutologousBLT miceBiopsyBloodBlood CellsBlood specimenCD4 Positive T LymphocytesCRISPR/Cas technologyCellsChlamydia trachomatisContainmentCorrelative StudyDataDevelopmentDoctor of PhilosophyEducationEngraftmentEvolutionFetal LiverFundingFutureGenerationsGrantHIVHIV InfectionsHIV/TBHealthcareHematopoieticHematopoietic stem cellsHumanImmuneImmune responseImmune systemImmunityImmunizationImmunoglobulinsImmunologic Deficiency SyndromesInfectionInvestigationKnock-in MouseLeukocytesLightLiverMacacaMacaca mulattaManuscriptsMediatingModelingMucous MembraneMusOperative Surgical ProceduresPathogenesisPatientsPersonsPhasePreparationPriceProceduresResearchResearch PersonnelSIVSamplingServicesSourceSystemT-LymphocyteTherapeuticThymic TissueTissue SampleTissuesUmbilical Cord BloodUnited States National Institutes of HealthUniversitiesVaccinesVirus Diseasesbioluminescence imagingcareerco-infectioncostexperimental studyhuman fetal thymushuman subjecthuman tissuehumanized mouseimplantationimprovedin vivoin vivo imaginginsightintravital microscopymembermicroscopic imagingmouse modelmultiphoton imagingnonhuman primatenucleaseperipheral bloodprogramsreconstitutionresponsesuccesstreatment effectvoucher
项目摘要
PROJECT SUMMARY/ABSTRACT
Human Immune System Mouse Core (Core H)
The Human Immune System Mouse Core (HISMC) will provide HU CFAR investigators with humanized mouse
models in which to study human immunodeficiency virus (HIV) infection. In addition, the HISMC will support
early career HU CFAR investigators to access these models through a Voucher program.
Despite extensive correlative studies of HIV-infected persons and ex vivo studies of peripheral blood cells and
tissue biopsies, fundamental questions about HIV pathogenesis and immunity remain unanswered. The ability
to study HIV through controlled perturbations of the immune system is limited in human subjects, and limited
access to human tissue samples makes the investigation of HIV replication and human immune responses to
HIV difficult in compartments other than the blood. Investigators have therefore turned to animal models, but
unfortunately an ideal animal model of HIV infection has remained elusive. Although simian immunodeficiency
virus (SIV) infection of rhesus macaques has provided many critically important insights into retroviral
pathogenesis and immunity, there are differences inherent in macaque immune responses to SIV and human
responses to HIV. Moreover, expenses associated with NHP studies limit access to this model. To address
these limitations, chimeric “humanized mice” with human immune cells have been generated. The HU CFAR
HISMC generates complementary humanized mouse models: human peripheral blood leukocytes (hu-PBL)
mice, hematopoietic stem cells (hu-HSC) mice and bone marrow-liver-thymus (BLT) mice. Studies supported
by the HISMC have demonstrated that these mice recapitulate multiple aspects of HIV infection in humans
such as the presence of an “eclipse phase” of infection following intravaginal challenge; similar depletion of
CD4+ T cell in peripheral blood and mucosal tissues following infection; and support advanced in vivo imaging
of HIV infection by multiphoton-intravital microscopy and bioluminescence imaging. They also offer a model to
study the effect of treatment, such as ART or antibodies, against HIV.
In the coming funding period, the HISMC will provide access to these models of humanized mice as a new
MGH/Partners Healthcare Core. As such, all costs involved in the generation of the mice and their
experimental manipulations are included in the price of the services. The CFAR support will be entirely
directed towards a voucher program to support access of early career HU CFAR investigators to these
services. These vouchers will cover costs related to humanized mice experiments and will be restricted to early
career HU CFAR investigators who have no grant funding for humanized mouse studies from other sources.
项目概要/摘要
人体免疫系统鼠标核心 (Core H)
人类免疫系统小鼠核心 (HISMC) 将为 HU CFAR 研究人员提供人源化小鼠
研究人类免疫缺陷病毒(HIV)感染的模型。此外,HISMC 将支持
早期职业 HU CFAR 研究人员通过优惠券计划访问这些模型。
尽管对 HIV 感染者进行了广泛的相关研究,并对外周血细胞和
尽管组织活检尚未解决,但有关艾滋病毒发病机制和免疫的基本问题仍未得到解答。能力
通过控制免疫系统的扰动来研究艾滋病毒在人类受试者中是有限的,并且有限
获取人体组织样本可以研究 HIV 复制和人体免疫反应
HIV很难在血液以外的其他部位存在。因此,研究人员转向动物模型,但是
不幸的是,理想的艾滋病毒感染动物模型仍然难以捉摸。虽然猿猴免疫缺陷
恒河猴病毒(SIV)感染为逆转录病毒提供了许多至关重要的见解
发病机制和免疫方面,猕猴对 SIV 的免疫反应与人类存在固有的差异
对艾滋病毒的反应。此外,与 NHP 研究相关的费用限制了该模型的使用。致地址
这些限制,与人类免疫细胞嵌合的“人源化小鼠”已经产生。 HU CFAR
HISMC 生成互补的人源化小鼠模型:人外周血白细胞 (hu-PBL)
小鼠、造血干细胞(hu-HSC)小鼠和骨髓-肝-胸腺(BLT)小鼠。支持研究
HISMC 的研究表明,这些小鼠重现了人类 HIV 感染的多个方面
例如阴道内感染后出现感染的“日食期”;类似的耗尽
感染后外周血和粘膜组织中CD4+ T细胞;并支持先进的体内成像
通过多光子活体显微镜和生物发光成像研究艾滋病毒感染。他们还提供了一个模型
研究抗艾滋病毒治疗(例如 ART 或抗体)的效果。
在接下来的资助期内,HISMC 将提供这些人源化小鼠模型作为新的
MGH/合作伙伴医疗保健核心。因此,产生小鼠及其后代的所有成本
实验操作包含在服务价格中。 CFAR 支持将完全由
针对代金券计划,以支持早期职业 HU CFAR 调查员获得这些
服务。这些优惠券将涵盖与人源化小鼠实验相关的费用,并将仅限于早期
职业 HU CFAR 研究人员,没有其他来源的人源化小鼠研究资助。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alejandro Benjamin Balazs其他文献
Alejandro Benjamin Balazs的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alejandro Benjamin Balazs', 18)}}的其他基金
AAV Vectored Delivery of Broadly Neutralizing Antibodies with Optimal Innate Functionality Against HIV
AAV 载体递送具有针对 HIV 的最佳先天功能的广泛中和抗体
- 批准号:
10762553 - 财政年份:2023
- 资助金额:
$ 16.81万 - 项目类别:
Development of Vectored ImmunoProphylaxis as a strategy against HIV
开发载体免疫预防作为抗 HIV 策略
- 批准号:
8411105 - 财政年份:2014
- 资助金额:
$ 16.81万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 16.81万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 16.81万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 16.81万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 16.81万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 16.81万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 16.81万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 16.81万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 16.81万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 16.81万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 16.81万 - 项目类别:
Research Grant